Non-viral gene delivery methods

Current Pharmaceutical Biotechnology

Volumn 14, Issue 1, 2013, Pages 46-60

  Wang, Weiwei ^a,b   Li, Wenzhong ^a,b   Ma, Nan ^a,b   Steinhoff, Gustav ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

Chemical gene delivery; Gene therapy; Lipoplex; Non viral gene delivery; Physical gene delivery; Polyplex; Transfection

Indexed keywords

DIOLEOYLPHOSPHATIDYLETHANOLAMINE; INTERLEUKIN 12; LIPOSOME; POLYETHYLENEIMINE; POLYMER; SIGNAL PEPTIDE; VASCULOTROPIN C;

DNA DEGRADATION; ELECTROPORATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE GUN; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HYDRODYNAMICS BASED TRANSFECTION; JET INJECTION; MICROINJECTION; MICROVASCULATURE; NEEDLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR PORE COMPLEX; PHASE 1 CLINICAL TRIAL (TOPIC); RETICULOENDOTHELIAL SYSTEM; REVIEW;

ANIMALS; GENE TRANSFER TECHNIQUES; HUMANS; LIPOSOMES; POLYMERS;

EID: 84872588385     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920113804805278     Document Type: Review

References (250)

1. Segura, T.; Shea, L. D. Materials for non-viral gene delivery. Ann. Rev. Mater Res., 2001, 31, 25-46.
2. Thomas, M.; Klibanov, A. M. Non-viral gene therapy: polycationmediated DNA delivery. Appl. Microbiol. Biot., 2003, 62(1), 27-34.
3. Boulaiz, H.; Marchal, J. A.; Prados, J.; Melguizo, C.; Aranega, A. Non-viral and viral vectors for gene therapy. Cell Mol. Biol., 2005, 51(1), 3-22.
4. Courties, G.; Presumey, J.; Duroux-Richard, I.; Jorgensen, C.; Apparailly, F. RNA interference-based gene therapy for successful treatment of rheumatoid arthritis. Expert Opin. Biol. Ther., 2009, 9(5), 535-538.
5. Emmrich, S.; Wang, W. W.; John, K.; Li, W. Z.; Putzer, B. M. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo. Mol. Cancer, 2009, 8, 61.
6. Brown, B. D.; Venneri, M. A.; Zingale, A.; Sergi, L. S.; Naldini, L. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med., 2006, 12(5), 585-591.
7. Asparuhova, M. B.; Barde, I.; Trono, D.; Schranz, K.; Schumperli, D. Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication. J. Gene. Med., 2008, 10(10), 1059-1070.
8. Ravet, E.; Lulka, H.; Gross, F.; Casteilla, L.; Buscail, L.; Cordelier, P. Using lentiviral vectors for efficient pancreatic cancer gene therapy. Cancer Gene Ther., 2010, 17(5), 315-324.
9. Cutroneo, K. R. Gene therapy for tissue regeneration. J. Cell Biochem., 2003, 88(2), 418-425.
10. Samson, S. L.; Gonzalez, E. V.; Yechoor, V.; Bajaj, M.; Oka, K.; Chan, L. Gene Therapy for diabetes: metabolic effects of helperdependent adenoviral exendin 4 expression in a diet-induced obesity mouse model (vol 16, pg 1805, 2008). Mol. Ther., 2009, 17(10), 1831-1831.
11. Rich, D. P.; Couture, L. A.; Cardoza, L. M.; Guiggio, V. M.; Armentano, D.; Espino, P. C.; Hehir, K.; Welsh, M. J.; Smith, A. E.; Gregory, R. J. Development and analysis of recombinant adenoviruses for gene-therapy of cystic-fibrosis. Hum. Gene Ther., 1993, 4(4), 461-476.
12. Mann, M. J.; Whittemore, A. D.; Donaldson, M. C.; Belkin, M.; Conte, M. S.; Polak, J. F.; Orav, E. J.; Ehsan, A.; Dell'Acqua, G.; Dzau, V. J. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet, 1999, 354(9189), 1493-1498.
13. Capowski, E. E.; Schneider, B. L.; Ebert, A. D.; Seehus, C. R.; Szulc, J.; Zufferey, R.; Aebischer, P.; Svendsen, C. N. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J. Neurosci. Meth., 2007, 163(2), 338-349.
14. Chang, P. L.; Bowie, K. M. Development of engineered cells for implantation in gene therapy. Adv. Drug Deliv. Rev., 1998, 33(1-2), 31-43.
15. Okumura, K.; Nakase, M.; Nakamura, S.; Kamei, T.; Inui, M.; Tagawa, T. Bax gene therapy for human osteosarcoma using cationic liposomes in vivo. Oncol. Rep., 2007, 17(4), 769-773.
16. Tanaka, M.; Grossman, H. B. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin. Gene Ther., 2003, 10(19), 1636-1642.
17. Zaiss, A. K.; Muruve, D. A. Immune responses to adeno-associated virus vectors. Curr. Gene Ther., 2005, 5(3), 323-331.
18. Azzam, T.; Domb, A. J. Current developments in gene transfection agents. Curr. Drug Deliv., 2004, 1(2), 165-193.
19. Sun, J. Y.; Anand-Jawa, V.; Chatterjee, S.; Wong, K. K. Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther., 2003, 10(11), 964-976.
20. Smith, A. E. Viral vectors in gene-therapy. Annu. Rev. Microbiol., 1995, 49, 807-838.
21. Check, E. Gene therapy: A tragic setback. Nature, 2002, 420(6912), 116-118.
22. Zheng, C. Y.; Goldsmith, C. M.; O'Connell, B. C.; Baum, B. J. Adenoviral vector cytotoxicity depends in part on the transgene encoded. Biochem. Bioph. Res. Co, 2000, 274(3), 767-771.
23. Gordon, J. W. High toxicity, low receptor density, and low integration frequency severely impede the use of adenovirus vectors for production of transgenic mice. Biol. Reprod., 2002, 67(4), 1172-1179.
24. Teramoto, S.; Johnson, L. G.; Huang, W. H.; Leigh, M. W.; Boucher, R. C. Effect of adenoviral vector infection on cellproliferation in cultured primary human airway epithelial-cells. Hum. Gene. Ther., 1995, 6(8), 1045-1053.
25. Lavertu, M.; Methot, S.; Tran-Khanh, N.; Buschmann, M. D. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials, 2006, 27(27), 4815-4824.
26. De Laporte, L.; Rea, J. C.; Shea, L. D. Design of modular non-viral gene therapy vectors. Biomaterials, 2006, 27(7), 947-954.
27. Zeng, J. M.; Wang, X.; Wang, S. Self-assembled ternary complexes of plasmid DNA, low molecular weight polyethylenimine and targeting peptide for nonviral gene delivery into neurons. Biomaterials, 2007, 28(7), 1443-1451.
28. Aslan, H.; Zilberman, Y.; Arbeli, V.; Sheyn, D.; Matan, Y.; Liebergall, M.; Li, J. Z.; Helm, G. A.; Gazit, D.; Gazit, Z. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng., 2006, 12(4), 877-889.
29. Schena, M.; Heller, R. A.; Theriault, T. P.; Konrad, K.; Lachenmeier, E.; Davis, R. W. Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol., 1998, 16(7), 301-306.
30. Romano, G.; Michell, P.; Pacilio, C.; Giordano, A. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Stem Cells, 2000, 18(1), 19-39.
31. Lundstrom, K.; Boulikas, T. Viral and non-viral vectors in gene therapy: Technology development and clinical trials. Technol. Cancer Res. T, 2003, 2(5), 471-485.
32. Chowdhury, E. H. Nuclear targeting of viral and non-viral DNA. Expert Opin. Drug Deliv., 2009, 6(7), 697-703.
33. Romano, G.; Pacilio, C.; Giordano, A. Gene transfer technology in therapy: current applications and future goals. Stem Cells, 1999, 17(4), 191-202.
34. Wang, Y.; Yuan, F. Delivery of viral vectors to tumor cells: Extracellular transport, systemic distribution, and strategies for improvement. Ann. Biomed. Eng., 2006, 34(1), 114-127.
35. Wiethoff, C. M.; Middaugh, C. R. Barriers to nonviral gene delivery. J. Pharm. Sci., 2003, 92(2), 203-217.
36. Kawabata, K.; Takakura, Y.; Hashida, M. The fate of plasmid DNA after intravenous-injection in mice-involvement of scavenger receptors in its hepatic-uptake. Pharm. Res., 1995, 12(6), 825-830.
37. Kircheis, R.; Wightman, L.; Kursa, M.; Ostermann, E.; Wagner, E. Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment. Gene Ther., 2002, 9(11), 731-735.
38. Li, S. D.; Huang, L. Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer. Bba-Biomembranes, 2009, 1788(10), 2259-2266.
39. Al-Dosari, M. S.; Gao, X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J., 2009, 11(4), 671-681.
40. Jain, R. K. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev., 1997, 26(2-3), 71-90.
41. Wu, N. Z.; Da, D.; Rudoll, T. L.; Needham, D.; Whorton, A. R.; Dewhirst, M. W. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res., 1993, 53(16), 3765-3770.
42. Yuan, F.; Leunig, M.; Huang, S. K.; Berk, D. A.; Papahadjopoulos, D.; Jain, R. K. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res., 1994, 54(13), 3352-3356.
43. Medina-Kauwe, L. K.; Xie, J.; Hamm-Alvarez, S. Intracellular trafficking of nonviral vectors. Gene Ther., 2005, 12(24), 1734-1751.
44. Luzio, J. P.; Mullock, B. M.; Pryor, P. R.; Lindsay, M. R.; James, D. E.; Piper, R. C. Relationship between endosomes and lysosomes. Biochem. Soc. T, 2001, 29, 476-480.
45. Li, W. J.; Nicol, F.; Szoka, F. C. GALA: a designed synthetic pHresponsive amphipathic peptide with applications in drug and gene delivery. Adv. Drug Deliv. Rev, 2004, 56(7), 967-985.
46. Xu, Y. H.; Szoka, F. C. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry-Us, 1996, 35(18), 5616-5623.
47. Boussif, O.; Lezoualch, F.; Zanta, M. A.; Mergny, M. D.; Scherman, D.; Demeneix, B.; Behr, J. P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo-polyethylenimine. Proc. Natl. Acad. Sci. USA, 1995, 92(16), 7297-7301.
48. Moret, I.; Peris, J. E.; Guillem, V. M.; Benet, M.; Revert, F.; Dasi, F.; Crespo, A.; Alino, S. F. Stability of PEI-DNA and DOTAPDNA complexes: effect of alkaline pH, heparin and serum. J. Control Release, 2001, 76(1-2), 169-181.
49. Bachand, M.; Trent, A. M.; Bunker, B. C.; Bachand, G. D. Physical factors affecting kinesin-based transport of synthetic nanoparticle cargo. J. Nanosci. Nanotechnol., 2005, 5(5), 718-722.
50. Bastos, R.; Pante, N.; Burke, B. Nuclear pore complex proteins. Int. Rev. Cytol., 1995, 162B, 257-302.
51. Wente, S. R. Gatekeepers of the nucleus. Science, 2000, 288(5470), 1374-1377.
52. Chan, C. K.; Jans, D. A. Using nuclear targeting signals to enhance non-viral gene transfer. Immunol. Cell Biol., 2002, 80 (2), 119-130.
53. Cartier, R.; Reszka, R. Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems. Gene Ther., 2002, 9(3), 157-167.
54. Dean, D. A.; Dean, B. S.; Muller, S.; Smith, L. C. Sequence requirements for plasmid nuclear import. Exp. Cell Res., 1999, 253(2), 713-722.
55. Dean, D. A. Import of plasmid DNA into the nucleus is sequence specific. Exp. Cell Res., 1997, 230(2), 293-302.
56. Vacik, J.; Dean, B. S.; Zimmer, W. E.; Dean, D. A. Cell-specific nuclear import of plasmid DNA. Gene Ther., 1999, 6(6), 1006-1014.
57. Dean, D. A.; Strong, D. D.; Zimmer, W. E. Nuclear entry of nonviral vectors. Gene Ther., 2005, 12(11), 881-890.
58. Brunner, S.; Sauer, T.; Carotta, S.; Cotten, M.; Saltik, M.; Wagner, E. Cell cycle dependence of gene transfer by lipoplex polyplex and recombinant adenovirus. Gene Ther., 2000, 7(5), 401-407.
59. Brunner, S.; Furtbauer, E.; Sauer, T.; Kursa, M.; Wagner, E. Overcoming the nuclear barrier: Cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol. Ther., 2002, 5 (1), 80-86.
60. Mannisto, M.; Ronkko, S.; Matto, M.; Honkakoski, P.; Hyttinen, M.; Pelkonen, J.; Urtti, A. The role of cell cycle on polyplexmediated gene transfer into a retinal pigment epithelial cell line. J. Gene Med., 2005, 7(4), 466-476.
61. Prasmickaite, L.; Hogset, A.; Berg, K. The role of the cell cycle on the efficiency of photochemical gene transfection. Bba-Gen Subjects, 2002, 1570 (3), 210-218.
62. Bieber, T.; Meissner, W.; Kostin, S.; Niemann, A.; Elsasser, H. P. Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J. Control Release, 2002, 82(2-3), 441-454.
63. Godbey, W. T.; Wu, K. K.; Mikos, A. G. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA, 1999, 96 (9), 5177-5181.
64. Godbey, W. T.; Barry, M. A.; Saggau, P.; Wu, K. K.; Mikos, A. G. Poly(ethylenimine)-mediated transfection: A new paradigm for gene delivery. J. Biomed. Mater Res., 2000, 51(3), 321-328.
65. Davis, H. L.; Whalen, R. G.; Demeneix, B. A. Direct gene-transfer into skeletal-muscle invivo-factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther., 1993, 4(2), 151-159.
66. Wolf, D. P.; Thomson, J. A.; Zelinskiwooten, M. B.; Stouffer, R. L. Invitro fertilization-embryo transfer in nonhuman-primates-the technique and its applications. Mol. Reprod Dev., 1990, 27(3), 261-280.
67. Barber, M. A. A technic for the inoculation of bacteria and other substances into living cells. J. Infect. Dis., 1911, 8(3), 348-360.
68. Wolff, J. A.; Malone, R. W.; Williams, P.; Chong, W.; Acsadi, G.; Jani, A.; Felgner, P. L. Direct gene-transfer into mouse muscle invivo. Science, 1990, 247(4949), 1465-1468.
69. Herweijer, H.; Wolff, J. A. Progress and prospects: naked DNA gene transfer and therapy. Gene Ther., 2003, 10(6), 453-458.
70. Lui, V. W. Y.; Falo, L. D.; Huang, L. Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo. J. Gene Med., 2001, 3(4), 384-393.
71. Schreurs, M. W. J.; de Boer, A. J.; Figdor, C. G.; Adema, G. J. Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection. Cancer Res., 1998, 58(12), 2509-2514.
72. Schultz, J.; Pavlovic, J.; Strack, B.; Nawrath, M.; Moelling, K. Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA. Hum. Gene Ther., 1999, 10 (3), 407-417.
73. Song, K.; Chang, Y.; Prud'homme, G. J. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer. Gene Ther., 2000, 7(6), 481-492.
74. Losordo, D. W.; Vale, P. R.; Hendel, R. C.; Milliken, C. E.; Fortuin, F. D.; Cummings, N.; Schatz, R. A.; Asahara, T.; Isner, J. M.; Kuntz, R. E. Phase 1/2 placebo-controlled, double-blind, doseescalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation, 2002, 105(17), 2012-2018.
75. Wendell, D. M.; Hemond, B. D.; Hogan, N. C.; Taberner, A. J.; Hunter, I. W. The effect of jet parameters on jet injection. Conf. Proc. IEEE Eng. Med. Biol. Soc., 2006, 1, 5005-5008.
76. Ren, S.; Li, M.; Smith, J. M.; DeTolla, L. J.; Furth, P. A. Lowvolume jet injection for intradermal immunization in rabbits. BMC Biotechnol., 2002, 2, 10.
77. Stein, U.; Walther, W.; Stege, A.; Kaszubiak, A.; Fichtner, I.; Lage, H. Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA. Mol. Ther., 2008, 16(1), 178-186.
78. Walther, W.; Siegel, R.; Kobelt, D.; Knosel, T.; Dietel, M.; Bembenek, A.; Aumann, J.; Schleef, M.; Baier, R.; Stein, U.; Schlag, P. M. Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer. Clin. Cancer Res., 2008, 14(22), 7545-7553.
79. Lysakowski, C.; Dumont, L.; Tramer, M. R.; Tassonyi, E. A needle-free jet-injection system with lidocaine for peripheral intravenous cannula insertion: a randomized controlled trial with costeffectiveness analysis. Anesth. Analg., 2003, 96(1), 215-219.
80. Klein, T. M.; Wolf, E. D.; Wu, R.; Sanford, J. C. High-velocity microprojectiles for delivering nucleic-acids into living cells. Nature, 1987, 327(6117), 70-73.
81. Yang, N. S.; Burkholder, J.; Roberts, B.; Martinell, B.; McCabe, D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA, 1990, 87(24), 9568-9572.
82. Gao, X.; Kim, K. S.; Liu, D. X. Nonviral gene delivery: What we know and what is next. AAPS. J., 2007, 9(1), E92-E104.
83. Uchida, M.; Natsume, H.; Kobayashi, D.; Sugibayashi, K.; Morimoto, Y. Effects of particle size, helium gas pressure and microparticle dose on the plasma concentration of indomethacin after bombardment of indomethacin-loaded poly-L-lactic acid microspheres using a Helios (TM) gun system. Biol. Pharm. Bull., 2002, 25(5), 690-693.
84. O'Brien, J.; Lummis, S. C. R. An improved method of preparing microcarriers for biolistic transfection. Brain Res. Protoc., 2002, 10(1), 12-15.
85. Neumann, E.; Schaeferridder, M.; Wang, Y.; Hofschneider, P. H. Gene-transfer into mouse lyoma cells by electroporation in high electric-fields. Embo. J., 1982, 1(7), 841-845.
86. Titomirov, A. V.; Sukharev, S.; Kistanova, E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim. Biophys. Acta, 1991, 1088(1), 131-134.
87. Canatella, P. J.; Prausnitz, M. R. Prediction and optimization of gene transfection and drug delivery by electroporation. Gene Ther., 2001, 8(19), 1464-1469.
88. Weecharangsan, W.; Opanasopit, P.; Lee, R. J. In vitro gene transfer using cationic vectors, electroporation and their combination. Anticancer Res., 2007, 27(1A), 309-313.
89. Lin, Y. C.; Huang, M. Y. Electroporation microchips for in vitro gene transfection. J. Micromech. Microeng., 2001, 11(5), 542-547.
90. Golzio, M.; Mora, M. P.; Raynaud, C.; Delteil, C.; Teissie, J.; Rols, M. P. Control by osmotic pressure of voltage-induced permeabilization and gene transfer in mammalian cells. Biophy. J., 1998, 74(6), 3015-3022.
91. Rols, M. P.; Delteil, C.; Golzio, M.; Teissie, J. Control by ATP and ADP of voltage-induced mammalian-cell-membrane permeabilization, gene transfer and resulting expression. Eur. J. Biochem., 1998, 254(2), 382-388.
92. Daud, A. I.; DeConti, R. C.; Andrews, S.; Urbas, P.; Riker, A. I.; Sondak, V. K.; Munster, P. N.; Sullivan, D. M.; Ugen, K. E.; Messina, J. L.; Heller, R. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J. Clin. Oncol., 2008, 26(36), 5896-5903.
93. Gothelf, A.; Mir, L. M.; Gehl, J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev., 2003, 29(5), 371-387.
94. Heller, R.; Jaroszeski, M.; Atkin, A.; Moradpour, D.; Gilbert, R.; Wands, J.; Nicolau, C. In vivo gene electroinjection and expression in rat liver. Febs Lett., 1996, 389(3), 225-228.
95. Nishi, T.; Yoshizato, K.; Yamashiro, S.; Takeshima, H.; Sato, K.; Hamada, K.; Kitamura, I.; Yoshimura, T.; Saya, H.; Kuratsu, J.; Ushio, Y. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res., 1996, 56(5), 1050-1055.
96. Michigami, T.; Yamagata, M.; Ozono, K. Osteoprotegerin gene transfer into muscle by electroporation in vivo as efficient gene therapy for osteolytic bone diseases. J. Bone Miner Res., 2001, 16, S182-S182.
97. Aihara, H.; Miyazaki, J. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol., 1998, 16(9), 867-870.
98. Gehl, J.; Skovsgaard, T.; Mir, L. M. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Bba-Gen Subjects, 2002, 1569 (1-3), 51-58.
99. Mir, L. M.; Bureau, M. F.; Gehl, J.; Rangara, R.; Rouy, D.; Caillaud, J. M.; Delaere, P.; Branellec, D.; Schwartz, B.; Scherman, D. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA, 1999, 96(8), 4262-4267.
100. Dean, D. A.; Machado-Aranda, D.; Blair-Parks, K.; Yeldandi, A. V.; Young, J. L. Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Ther., 2003, 10(18), 1608-1615.
101. Pavselj, N.; Preat, V. DNA electrotransfer into the skin using a combination of one high-and one low-voltage pulse. J. Control Release, 2005, 106 (3), 407-415.
102. Dujardin, N.; Van der Smissen, P.; Preat, V. Topical gene transfer into rat skin using electroporation. Pharmaceut. Res., 2001, 18 (1), 61-66.
103. Rols, M. P.; Delteil, C.; Golzio, M.; Dumond, P.; Cros, S.; Teissie, J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat. Biotechnol., 1998, 16 (2), 168-171.
104. Cemazar, M.; Sersa, G.; Wilson, J.; Tozer, G. M.; Hart, S. L.; Grosel, A.; Dachs, G. U. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: Electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther., 2002, 9(4), 399-406.
105. Heller, L. C.; Heller, R. In vivo electroporation for gene therapy. Hum. Gene Ther., 2006, 17(9), 890-897.
106. Heller, L. C.; Ugen, K.; Heller, R. Electroporation for targeted gene transfer. Expert Opin. Drug Deliv., 2005, 2(2), 255-268.
107. Isaka, Y.; Imai, E. Electroporation-mediated gene therapy. Exp. Opin. Drug Deliv., 2007, 4(5), 561-571.
108. Gehl, J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand, 2003, 177(4), 437-447.
109. Sakai, M.; Nishikawa, M.; Thanaketpaisarn, O.; Yamashita, F.; Hashida, M. Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation. Gene Ther., 2005, 12(7), 607-616.
110. McMahon, J. M.; Wells, D. J. Electroporation for gene transfer to skeletal muscles-Current status. Biodrugs, 2004, 18(3), 155-165.
111. McMahon, J. M.; Signori, E.; Wells, K. E.; Fazio, V. M.; Wells, D. J. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase-increased expression with reduced muscle damage. Gene Ther., 2001, 8(16), 1264-1270.
112. Andre, F.; Mir, L. M. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther., 2004, 11, S33-S42.
113. Magin-Lachmann, C.; Kotzamanis, G.; D'Aiuto, L.; Cooke, H.; Huxley, C.; Wagner, E. In vitro and in vivo delivery of intact BAC DNA-comparison of different methods. J. Gene Med., 2004, 6(2), 195-209.
114. Canatella, P. J.; Prausnitz, M. R. Prediction and optimization of gene transfection and drug delivery by electroporation. Gene Ther., 2001, 8(19), 1464-1469.
115. Molnar, M. J.; Gilbert, R.; Lu, Y. F.; Liu, A. B.; Guo, A.; Larochelle, N.; Orlopp, K.; Lochmuller, H.; Petrof, B. J.; Nalbantoglu, J.; Karpati, G. Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles. Mol. Ther., 2004, 10(3), 447-455.
116. Durieux, A. C.; Bonnefoy, R.; Busso, T.; Freyssenet, D. In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage. J. Gene Med., 2004, 6(7), 809-816.
117. Gissel, H.; Clausen, T. Excitation-induced Ca2+ influx and skeletal muscle cell damage. Acta Physiol. Scand, 2001, 171(3), 327-334.
118. Endoh, M.; Koibuchi, N.; Sato, M.; Morishita, R.; Kanzaki, T.; Murata, Y.; Kaneda, Y. Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol. Ther., 2002, 5(5), 501-508.
119. Nozaki, T.; Ogawa, R.; Feril, L. B.; Kagiya, G.; Fuse, H.; Kondo, T. Enhancement of ultrasound-mediated gene transfection by membrane modification. J. Gene Med., 2003, 5(12), 1046-1055.
120. Ogawa, R.; Kagiya, G.; Feril, L. B.; Nakaya, N.; Nozaki, T.; Fuse, H.; Kondo, T. Ultrasound mediated intravesical transfection enhanced by treatment with lidocaine or heat. J. Urology, 2004, 172(4), 1469-1473.
121. Koch, S.; Pohl, P.; Cobet, U.; Rainov, N. G. Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects. Ultrasound Med. Biol., 2000, 26(5), 897-903.
122. Anwer, K.; Kao, G.; Proctor, B.; Anscombe, I.; Florack, V.; Earls, R.; Wilson, E.; McCreery, T.; Unger, E.; Rolland, A.; Sullivan, S. M. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther., 2000, 7(21), 1833-1839.
123. Kim, H. J.; Greenleaf, J. F.; Kinnick, R. R.; Bronk, J. T.; Bolander, M. E. Ultrasound-mediated transfection of mammalian cells. Hum. Gene Ther., 1996, 7(11), 1339-1346.
124. Tsunoda, S.; Mazda, O.; Oda, Y.; Iida, Y.; Akabame, S.; Kishida, T.; Masaharu, S. Y.; Asada, H.; Gojo, S.; Imanishi, J.; Matsubara, H.; Yoshikawa, T. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem. Bioph. Res. Co, 2005, 336(1), 118-127.
125. Unger, E. C.; Hersh, E.; Vannan, M.; Matsunaga, T. O.; McCreery, M. Local drug and gene delivery through microbubbles. Prog. Cardiovasc. Dis., 2001, 44(1), 45-54.
126. Sheyn, D.; Kimelman-Bleich, N.; Pelled, G.; Zilberman, Y.; Gazit, D.; Gazit, Z. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther., 2008, 15(4), 257-266.
127. Taniyama, Y.; Tachibana, K.; Hiraoka, K.; Aoki, M.; Yamamoto, S.; Matsumoto, K.; Nakamura, T.; Ogihara, T.; Kaneda, Y.; Morishita, R. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther., 2002, 9(6), 372-380.
128. McDannold, N.; Vykhodtseva, N.; Hynynen, K. Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med. Biol., 2008, 34(5), 834-840.
129. Liu, H. L.; Hua, M. Y.; Chen, P. Y.; Chu, P. C.; Pan, C. H.; Yang, H. W.; Huang, C. Y.; Wang, J. J.; Yen, T. C.; Wei, K. C. Bloodbrain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology, 2010, 255(2), 415-425.
130. Zhang, G.; Song, Y. K.; Liu, D. Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure. Gene Ther., 2000, 7(15), 1344-1349.
131. Liu, F.; Song, Y. K.; Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther., 1999, 6(7), 1258-1266.
132. Zhang, G.; Gao, X.; Song, Y. K.; Vollmer, R.; Stolz, D. B.; Gasiorowski, J. Z.; Dean, D. A.; Liu, D. Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther., 2004, 11(8), 675-682.
133. Al-Dosari, M. S.; Knapp, J. E.; Liu, D. Hydrodynamic delivery. Adv. Genet, 2005, 54, 65-82.
134. Yeikilis, R.; Gal, S.; Kopeiko, N.; Paizi, M.; Pines, M.; Braet, F.; Spira, G. Hydrodynamics based transfection in normal and fibrotic rats. World J. Gastroentero, 2006, 12(38), 6149-6155.
135. Romoren, K.; Thu, B. J.; Evensen, O. Expression of luciferase in selected organs following delivery of naked and formulated DNA to rainbow trout (Oncorhynchus mykiss) by different routes of administration. Fish Shellfish Immun., 2004, 16(2), 251-264.
136. Hamar, P.; Song, E. W.; Kokeny, G.; Chen, A.; Ouyang, N. T.; Lieberman, J. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA, 2004, 101(41), 14883-14888.
137. Liang, K. W.; Nishikawa, M.; Liu, F.; Sun, B.; Ye, Q.; Huang, L. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene. Ther., 2004, 11(11), 901-908.
138. Hino, T.; Yokota, T.; Ito, S.; Nishina, K.; Kang, Y. S.; Mori, S.; Hori, S.; Kanda, T.; Terasaki, T.; Mizusawa, H. In vivo delivery of small interfering RNA targeting brain capillary endothelial cells. Biochem. Biophys. Res. Commun., 2006, 340(1), 263-267.
139. Bradley, S. P.; Rastellini, C.; da Costa, M. A.; Kowalik, T. F.; Bloomenthal, A. B.; Brown, M.; Cicalese, L.; Basadonna, G. P.; Uknis, M. E. Gene silencing in the endocrine pancreas mediated by short-interfering RNA. Pancreas, 2005, 31(4), 373-379.
140. Fabre, J. W.; Grehan, A.; Whitehorne, M.; Sawyer, G. J.; Dong, X.; Salehi, S.; Eckley, L.; Zhang, X.; Seddon, M.; Shah, A. M.; Davenport, M.; Rela, M. Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava. Gene Ther., 2008, 15(6), 452-462.
141. Alino, S. F.; Herrero, M. J.; Noguera, I.; Dasi, F.; Sanchez, M. Pig liver gene therapy by noninvasive interventionist catheterism. Gene Ther., 2007, 14(4), 334-343.
142. Yoshino, H.; Hashizume, K.; Kobayashi, E. Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume. Gene Ther., 2006, 13(24), 1696-1702.
143. Liu, F.; Huang, L. Noninvasive gene delivery to the liver by mechanical massage. Hepatology, 2002, 35(6), 1314-1319.
144. Liu, F.; Lei, J.; Vollmer, R.; Huang, L. Mechanism of liver gene transfer by mechanical massage. Mol. Ther., 2004, 9(3), 452-457.
145. Felgner, P. L.; Gadek, T. R.; Holm, M.; Roman, R.; Chan, H. W.; Wenz, M.; Northrop, J. P.; Ringold, G. M.; Danielsen, M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA, 1987, 84 (21), 7413-7417.
146. Hashida, M.; Kawakami, S.; Yamashita, F. Lipid carrier systems for targeted drug and gene delivery. Chem. Pharm. Bull (Tokyo), 2005, 53(8), 871-880.
147. Zuhorn, I. S.; Engberts, J. B.; Hoekstra, D. Gene delivery by cationic lipid vectors: overcoming cellular barriers. Eur. Biophys. J, 2007, 36(4-5), 349-362.
148. Pedroso de Lima, M. C.; Simoes, S.; Pires, P.; Faneca, H.; Duzgunes, N. Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv. Drug Deliv. Rev., 2001, 47 (2-3), 277-294.
149. Liu, D.; Ren, T.; Gao, X. Cationic transfection lipids. Curr. Med. Chem., 2003, 10(14), 1307-1315.
150. Chesnoy, S.; Huang, L. Structure and function of lipid-DNA complexes for gene delivery. Annu. Rev. Biophys. Biomol. Struct., 2000, 29, 27-47.
151. Chesnoy, S.; Huang, L. Structure and function of lipid-DNA complexes for gene delivery. Annu. Rev. Bioph. Biom., 2000, 29, 27-47.
152. Ruysschaert, J. M.; el Ouahabi, A.; Willeaume, V.; Huez, G.; Fuks, R.; Vandenbranden, M.; Di Stefano, P. A novel cationic amphiphile for transfection of mammalian cells. Biochem. Biophys. Res. Commun., 1994, 203(3), 1622-1628.
153. Vigneron, J. P.; Oudrhiri, N.; Fauquet, M.; Vergely, L.; Bradley, J. C.; Basseville, M.; Lehn, P.; Lehn, J. M. Guanidinium-cholesterol cationic lipids: Efficient vectors for the transfection of eukaryotic cells. Proc. Natl. Acad. Sci. USA, 1996, 93(18), 9682-9686.
154. Solodin, I.; Brown, C. S.; Bruno, M. S.; Chow, C. Y.; Jang, E. H.; Debs, R. J.; Heath, T. D. A novel series of amphiphilic imidazolinium compounds for in-vitro and in-vivo gene delivery. Biochemistry-Us, 1995, 34(41), 13537-13544.
155. Lee, E. R.; Marshall, J.; Siegel, C. S.; Jiang, C. W.; Yew, N. S.; Nichols, M. R.; Nietupski, J. B.; Ziegler, R. J.; Lane, M. B.; Wang, K. X.; Wan, N. C.; Scheule, R. K.; Harris, D. J.; Smith, A. E.; Cheng, S. H. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther., 1996, 7(14), 1701-1717.
156. Felgner, J. H.; Kumar, R.; Sridhar, C. N.; Wheeler, C. J.; Tsai, Y. J.; Border, R.; Ramsey, P.; Martin, M.; Felgner, P. L. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem., 1994, 269(4), 2550-2561.
157. Ren, T.; Zhang, G. S.; Liu, F.; Liu, D. X. Synthesis and evaluation of vitamin D-based cationic lipids for gene delivery in vitro. Bioorg. Med. Chem. Lett., 2000, 10(9), 891-894.
158. Tang, F. X.; Hughes, J. A. Introduction of a disulfide bond into a cationic lipid enhances transgene expression of plasmid DNA. Biochem. Bioph. Res. Co, 1998, 242(1), 141-145.
159. Liu, F.; Qi, H.; Huang, L.; Liu, D. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther., 1997, 4(6), 517-523.
160. Hui, S. W.; Langner, M.; Zhao, Y. L.; Ross, P.; Hurley, E.; Chan, K. The role of helper lipids in cationic liposome-mediated gene transfer. Biophys. J., 1996, 71(2), 590-599.
161. Monk, K. W. C.; Cullis, P. R. Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys. J., 1997, 73(5), 2534-2545.
162. Simoes, S.; Slepushkin, V.; Gaspar, R.; de Lima, M. C. P.; Duzgunes, N. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther., 1998, 5(7), 955-964.
163. Galanis, E.; Hersh, E. M.; Stopeck, A. T.; Gonzalez, R.; Burch, P.; Spier, C.; Akporiaye, E. T.; Rinehart, J. J.; Edmonson, J.; Sobol, R. E.; Forscher, C.; Sondak, V. K.; Lewis, B. D.; Unger, E. C.; O'Driscoll, M.; Selk, L.; Rubin, J. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience. J. Clin. Oncol., 1999, 17(10), 3313-3323.
164. Koltover, I.; Salditt, T.; Radler, J. O.; Safinya, C. R. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science, 1998, 281 (5373), 78-81.
165. Zuidam, N. J.; Barenholz, Y. Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery. Bba-Biomembranes, 1998, 1368(1), 115-128.
166. Wheeler, C. J.; Felgner, P. L.; Tsai, Y. J.; Marshall, J.; Sukhu, L.; Doh, S. G.; Hartikka, J.; Nietupski, J.; Manthorpe, M.; Nichols, M.; Plewe, M.; Liang, X.; Norman, J.; Smith, A.; Cheng, S. H. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl. Acad. Sci. USA, 1996, 93(21), 11454-11459.
167. Harvie, P.; Wong, F. M. P.; Bally, M. B. Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation. Biophys. J., 1998, 75(2), 1040-1051.
168. Simoes, S.; Slepushkin, V.; Pires, P.; Gaspar, R.; de Lima, M. C. P.; Duzgunes, N. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides. Gene Ther., 1999, 6(11), 1798-1807.
169. ElOuahabi, A.; Thiry, M.; Pector, V.; Fuks, R.; Ruysschaert, J. M.; Vandenbranden, M. The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. Febs Lett., 1997, 414(2), 187-192.
170. Li, S.; Rizzo, M. A.; Bhattacharya, S.; Huang, L. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther., 1998, 5(7), 930-937.
171. Wang, J. K.; Guo, X.; Xu, Y. H.; Barron, L.; Szoka, F. C. Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. J. Med. Chem., 1998, 41(13), 2207-2215.
172. Liu, Y.; Mounkes, L. C.; Liggitt, H. D.; Brown, C. S.; Solodin, I.; Heath, T. D.; Debs, R. J. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat. Biotechnol., 1997, 15(2), 167-173.
173. Hong, K. L.; Zheng, W. W.; Baker, A.; Papahadjopoulos, D. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. Febs Lett., 1997, 400(2), 233-237.
174. Song, Y. K.; Liu, D. X. Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration. Bba-Biomembranes, 1998, 1372(1), 141-150.
175. Rao, N. M.; Gopal, V. Cell biological and biophysical aspects of lipid-mediated gene delivery. Biosci. Rep., 2006, 26(4), 301-324.
176. Sternberg, B.; Sorgi, F. L.; Huang, L. New structures in complexformation between dna and cationic liposomes visualized by freeze-fracture electron-microscopy. Febs Lett., 1994, 356(2-3), 361-366.
177. Radler, J. O.; Koltover, I.; Salditt, T.; Safinya, C. R. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science, 1997, 275(5301), 810-814.
178. Templeton, N. S.; Lasic, D. D.; Frederik, P. M.; Strey, H. H.; Roberts, D. D.; Pavlakis, G. N. Improved DNA: Liposome complexes for increased systemic delivery and gene expression. Nat. Biotechnol., 1997, 15(7), 647-652.
179. Safinya, C. R. Structures of lipid-DNA complexes: supramolecular assembly and gene delivery. Curr. Opin. Struct. Biol., 2001, 11(4), 440-448.
180. Pires, P.; Simoes, S.; Nir, S.; Gaspar, R.; Duzgunes, N.; de Lima, M. C. P. Interaction of cationic liposomes and their DNA complexes with monocytic leukemia cells. Bba-Biomembranes, 1999, 1418(1), 71-84.
181. Zabner, J.; Fasbender, A. J.; Moninger, T.; Poellinger, K. A.; Welsh, M. J. Cellular and molecular barriers to gene-transfer by a cationic lipid. J. Biol. Chem., 1995, 270(32), 18997-19007.
182. Cheng, P. W. Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin. Hum. Gene Ther., 1996, 7(3), 275-282.
183. Yanagihara, K.; Cheng, P. W. Lectin enhancement of the lipofection efficiency in human lung carcinoma cells. Bba-Gen Subjects, 1999, 1472(1-2), 25-33.
184. Yanagihara, K.; Cheng, H.; Cheng, P. W. Effects of epidermal growth factor, transferrin, and insulin on lipofection efficiency in human lung carcinoma cells. Cancer Gene Ther., 2000, 7(1), 59-65.
185. Reddy, J. A.; Abburi, C.; Hofland, H.; Howard, S. J.; Vlahov, I.; Wils, P.; Leamon, C. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther., 2002, 9(22), 1542-1550.
186. Almofti, M. R.; Harashima, H.; Shinohara, Y.; Almofti, A.; Li, W. H.; Kiwada, H. Lipoplex size determines lipofection efficiency with or without serum. Mol. Membr. Biol., 2003, 20(1), 35-43.
187. Ross, P. C.; Hui, S. W. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther., 1999, 6(4), 651-659.
188. Goncalves, E.; Debs, R. J.; Heath, T. D. The effect of liposome size on the final lipid/DNA ratio of cationic lipoplexes. Biophys. J., 2004, 86(3), 1554-1563.
189. Gershon, H.; Ghirlando, R.; Guttman, S. B.; Minsky, A. Mode of formation and structural features of DNA cationic liposome complexes used for transfection. Biochemistry-Us, 1993, 32(28), 7143-7151.
190. Hirko, A.; Tang, F. X.; Hughes, J. A. Cationic lipid vectors for plasmid DNA delivery. Curr. Med. Chem., 2003, 10(14), 1185-1193.
191. Ferrari, M. E.; Rusalov, D.; Enas, J.; Wheeler, C. J. Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes. Nucleic Acids Res., 2002, 30(8), 1808-1816.
192. Congiu, A.; Pozzi, D.; Esposito, C.; Castellano, C.; Mossa, G. Correlation between structure and transfection efficiency: a study of DC-Chol-DOPE/DNA complexes. Colloid Surface B, 2004, 36(1), 43-48.
193. Liu, Y.; Fong, S.; Debs, R. J. Cationic liposome-mediated gene delivery in vivo. Methods Enzymol., 2003, 373, 536-550.
194. Elouahabi, A.; Ruysschaert, J. M. Formation and intracellular trafficking of lipoplexes and polyplexes. Mol. Ther., 2005, 11(3), 336-347.
195. Brunner, S.; Sauer, T.; Carotta, S.; Cotten, M.; Saltik, M.; Wagner, E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther., 2000, 7(5), 401-407.
196. Porteous, D. J.; Dorin, J. R.; McLachlan, G.; Davidson-Smith, H.; Davidson, H.; Stevenson, B. J.; Carothers, A. D.; Wallace, W. A.; Moralee, S.; Hoenes, C.; Kallmeyer, G.; Michaelis, U.; Naujoks, K.; Ho, L. P.; Samways, J. M.; Imrie, M.; Greening, A. P.; Innes, J. A. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther., 1997, 4(3), 210-218.
197. Laitinen, M.; Hartikainen, J.; Hiltunen, M. O.; Eranen, J.; Kiviniemi, M.; Narvanen, O.; Makinen, K.; Manninen, H.; Syvanne, M.; Martin, J. F.; Laakso, M.; Yla-Herttuala, S. Cathetermediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum. Gene Ther., 2000, 11(2), 263-270.
198. Ishii, T.; Okahata, Y.; Sato, T. Mechanism of cell transfection with plasmid/chitosan complexes. Bba-Biomembranes, 2001, 1514(1), 51-64.
199. Sato, T.; Ishii, T.; Okahata, Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials, 2001, 22(15), 2075-2080.
200. Tang, M. X.; Redemann, C. T.; Szoka, F. C. Jr. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug. Chem., 1996, 7(6), 703-714.
201. Wu, G. Y.; Wu, C. H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem., 1987, 262(10), 4429-4432.
202. Emi, N.; Kidoaki, S.; Yoshikawa, K.; Saito, H. Gene transfer mediated by polyarginine requires a formation of big carrier-complex of DNA aggregate. Biochem. Bioph. Res. Co, 1997, 231(2), 421-424.
203. Koo, H.; Jin, G. W.; Park, J. S. In vitro gene delivery to HepG2 cells with a novel galactosylated polyornithine. B Korean Chem. Soc., 2009, 30(7), 1622-1624.
204. Ramsay, E.; Gumbleton, M. Polylysine and polyornithine gene transfer complexes: A study of complex stability and cellular uptake as a basis for their differential in-vitro transfection efficiency. J. Drug Target, 2002, 10(1), 1-9.
205. Balicki, D.; Putnam, C. D.; Scaria, P. V.; Beutler, E. Structure and function correlation in histone H2A peptide-mediated gene transfer. Proc. Natl. Acad. Sci. USA, 2002, 99(11), 7467-7471.
206. Park, Y. J.; Liang, J. F.; Ko, K. S.; Kim, S. W.; Yang, V. C. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. J. Gene Med., 2003, 5(8), 700-711.
207. Boussif, O.; Lezoualc'h, F.; Zanta, M. A.; Mergny, M. D.; Scherman, D.; Demeneix, B.; Behr, J. P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA, 1995, 92(16), 7297-7301.
208. Li, W.; Ma, N.; Ong, L. L.; Nesselmann, C.; Klopsch, C.; Ladilov, Y.; Furlani, D.; Piechaczek, C.; Moebius, J. M.; Lutzow, K.; Lendlein, A.; Stamm, C.; Li, R. K.; Steinhoff, G. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells, 2007, 25 (8), 2118-2127.
209. Wang, J.; Mao, H. Q.; Leong, K. W. A novel biodegradable gene carrier based on polyphosphoester. J. Am. Chem. Soc., 2001, 123(38), 9480-9481.
210. Wagner, E.; Cotten, M.; Foisner, R.; Birnstiel, M. L. Transferrinpolycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proc. Natl. Acad. Sci. USA, 1991, 88(10), 4255-4259.
211. Cotten, M.; Langlerouault, F.; Kirlappos, H.; Wagner, E.; Mechtler, K.; Zenke, M.; Beug, H.; Birnstiel, M. L. Transferrin Polycation-Mediated Introduction of DNA into Human Leukemic-Cells-Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc. Natl. Acad. Sci. USA, 1990, 87(11), 4033-4037.
212. Wagner, E.; Zenke, M.; Cotten, M.; Beug, H.; Birnstiel, M. L. Transferrin-Polycation Conjugates as Carriers for DNA Uptake into Cells. Proc. Natl. Acad. Sci. USA, 1990, 87(9), 3410-3414.
213. Mislick, K. A.; Baldeschwieler, J. D.; Kayyem, J. F.; Meade, T. J. Transfection of folate-polylysine DNA complexes-evidence for lysosomal delivery. Bioconjug. Chem., 1995, 6(5), 512-515.
214. Chen, J. B.; Gamou, S.; Takayanagi, A.; Shimizu, N. A novel gene delivery system using egf receptor-mediated endocytosis. Febs Lett., 1994, 338(2), 167-169.
215. Schachtschabel, U.; Pavlinkova, G.; Lou, D. Y.; Kohler, H. Antibody-mediated gene delivery for B-cell lymphoma in vitro. Cancer Gene Ther., 1996, 3(6), 365-372.
216. Shimizu, N. Immunogene approach toward cancer therapy using erythrocyte growth factor receptor-mediated gene delivery (vol 3, pg 113, 1996). Cancer Gene Ther., 1996, 3(4), 279-279.
217. Ferkol, T.; Perales, J. C.; Eckman, E.; Kaetzel, C. S.; Hanson, R. W.; Davis, P. B. Gene-transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. J. Clin. Invest., 1995, 95(2), 493-502.
218. Sosnowski, B. A.; Gonzalez, A. M.; Chandler, L. A.; Buechler, Y. J.; Pierce, G. F.; Baird, A. Targeting DNA to cells with basic fibroblast growth factor (FGF2). J. Biol. Chem., 1996, 271(52), 33647-33653.
219. Merdan, T.; Kunath, K.; Fischer, D.; Kopecek, J.; Kissel, T. Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm. Res., 2002, 19(2), 140-146.
220. Pouton, C. W.; Lucas, P.; Thomas, B. J.; Uduehi, A. N.; Milroy, D. A.; Moss, S. H. Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J. Control Release, 1998, 53(1-3), 289-299.
221. Wagner, E.; Plank, C.; Zatloukal, K.; Cotten, M.; Birnstiel, M. L. Influenza-virus hemagglutinin-Ha-2 N-terminal fusogenic peptides augment gene-transfer by transferrin polylysine DNA complexes-toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA, 1992, 89(17), 7934-7938.
222. Lee, H.; Jeong, J. H.; Park, T. G. PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J. Control Release, 2002, 79(1-3), 283-291.
223. Wagner, E.; Kloeckner, J. Gene delivery using polymer therapeutics. Adv. Polym. Sci., 2006, 192, 135-173.
224. Duguid, J. G.; Li, C.; Shi, M.; Logan, M. J.; Alila, H.; Rolland, A.; Tomlinson, E.; Sparrow, J. T.; Smith, L. C. A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy. Biophys. J., 1998, 74(6), 2802-2814.
225. Ward, C. M.; Read, M. L.; Seymour, L. W. Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood, 2001, 97(8), 2221-2229.
226. Dash, P. R.; Read, M. L.; Barrett, L. B.; Wolfert, M.; Seymour, L. W. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther., 1999, 6(4), 643-650.
227. Kwoh, D. Y.; Coffin, C. C.; Lollo, C. P.; Jovenal, J.; Banaszczyk, M. G.; Mullen, P.; Phillips, A.; Amini, A.; Fabrycki, J.; Bartholomew, R. M.; Brostoff, S. W.; Carlo, D. J. Stabilization of poly-Llysine/ DNA polyplexes for in vivo gene delivery to the liver. Bba-Gene Struct Expr., 1999, 1444(2), 171-190.
228. Ward, C. M.; Pechar, M.; Oupicky, D.; Ulbrich, K.; Seymour, L. W. Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo. J. Gene Med., 2002, 4(5), 536-547.
229. Choi, Y. H.; Liu, F.; Park, J. S.; Kim, S. W. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-targeted gene carrier. Bioconjug. Chem., 1998, 9(6), 708-718.
230. Kwok, K. Y.; Park, Y.; Yang, Y. S.; McKenzie, D. L.; Liu, Y. H.; Rice, K. G. In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates. J. Pharm. Sci., 2003, 92(6), 1174-1185.
231. Marschall, P.; Malik, N.; Larin, Z. Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine. Gene Ther., 1999, 6(9), 1634-1637.
232. Campeau, P.; Chapdelaine, P.; Seigneurin-Venin, S.; Massie, B.; Tremblay, J. P. Transfection of large plasmids in primary human myoblasts. Gene Ther., 2001, 8(18), 1387-1394.
233. Akinc, A.; Thomas, M.; Klibanov, A. M.; Langer, R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med., 2005, 7(5), 657-663.
234. Fischer, D.; Bieber, T.; Li, Y. X.; Elsasser, H. P.; Kissel, T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res., 1999, 16(8), 1273-1279.
235. Wang, W. W.; Li, W. Z.; Ong, L. L.; Furlani, D.; Kaminski, A.; Liebold, A.; Lutzow, K.; Lendlein, A.; Wang, J.; Li, R. K.; Steinhoff, G.; Ma, N. Localized SDF-1alpha gene release mediated by collagen substrate induces CD117+stem cells homing. J. Cell Mol. Med., 2010, 14(1-2), 392-402.
236. Wang, W.; Li, W.; Ong, L. L.; Lutzow, K.; Lendlein, A.; Furlani, D.; Gabel, R.; Kong, D.; Wang, J.; Li, R. K.; Steinhoff, G.; Ma, N. Localized and sustained SDF-1 gene release mediated by fibronectin films: A potential method for recruiting stem cells. Int. J. Artif. Organs, 2009, 32(3), 141-149.
237. Forrest, M. L.; Koerber, J. T.; Pack, D. W. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug. Chem., 2003, 14(5), 934-940.
238. Ahn, C. H.; Chae, S. Y.; Bae, Y. H.; Kim, S. W. Biodegradable poly (ethylenimine) for plasmid DNA delivery. J. Control Release, 2002, 80(1-3), 273-282.
239. Gosselin, M. A.; Guo, W. J.; Lee, R. J. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug. Chem., 2001, 12(6), 989-994.
240. Tang, G. P.; Guo, H. Y.; Alexis, F.; Wang, X.; Zeng, S.; Lim, T. M.; Ding, J.; Yang, Y. Y.; Wang, S. Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system. J. Gene Med., 2006, 8(6), 736-744.
241. Ferrari, S.; Moro, E.; Pettenazzo, A.; Behr, J. P.; Zacchello, F.; Scarpa, M. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther., 1997, 4(10), 1100-1106.
242. Coll, J. L.; Chollet, P.; Brambilla, E.; Desplanques, D.; Behr, J. P.; Favrot, M. In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum. Gene Ther., 1999, 10(10), 1659-1666.
243. Wightman, L.; Kircheis, R.; Rossler, V.; Carotta, S.; Ruzicka, R.; Kursa, M.; Wagner, E. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med., 2001, 3(4), 362-372.
244. Goula, D.; Benoist, C.; Mantero, S.; Merlo, G.; Levi, G.; Demeneix, B. A. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther., 1998, 5(9), 1291-1295.
245. Tan, Y.; Whitmore, M.; Li, S.; Frederik, P.; Huang, L. LPD nanoparticles--novel nonviral vector for efficient gene delivery. Methods Mol. Med., 2002, 69, 73-81.
246. Ueno, N. T.; Bartholomeusz, C.; Xia, W.; Anklesaria, P.; Bruckheimer, E. M.; Mebel, E.; Paul, R.; Li, S.; Yo, G. H.; Huang, L.; Hung, M. C. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene. Cancer Res., 2002, 62(22), 6712-6716.
247. Gao, X.; Huang, L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry-Us, 1996, 35(3), 1027-1036.
248. Sorgi, F. L.; Bhattacharya, S.; Huang, L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther., 1997, 4(9), 961-968.
249. Li, S.; Huang, L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther., 1997, 4(9), 891-900.
250. Lee, R. J.; Huang, L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem., 1996, 271(14), 8481-8487.